These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 33619191
1. Microinvasive pars plana vitrectomy versus panretinal photocoagulation in the treatment of severe non-proliferative diabetic retinopathy (the VIP study): study protocol for a randomised controlled trial. Zheng W, Chen S, Ding X, Lai K, Xiao S, Lin Y, Liu B, Jin L, Li J, Wu Y, Ma Y, Lu L, Liu Y, Li T. BMJ Open; 2021 Feb 22; 11(2):e043371. PubMed ID: 33619191 [Abstract] [Full Text] [Related]
2. Predictors of visual outcome after pars plana vitrectomy secondary to proliferative diabetic retinopathy. Nisic F, Gadzo AP, Fajkic A, Nisic A, Miokovic AP, Damjanovic G, Begic E, Beslic N, Lepara O. Rom J Ophthalmol; 2023 Feb 22; 67(3):283-288. PubMed ID: 37876512 [Abstract] [Full Text] [Related]
12. Cost Evaluation of Early Vitrectomy versus Panretinal Photocoagulation and Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy. Lin J, Chang JS, Yannuzzi NA, Smiddy WE. Ophthalmology; 2018 Sep 24; 125(9):1393-1400. PubMed ID: 29606379 [Abstract] [Full Text] [Related]
13. Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial. Sivaprasad S, Prevost AT, Vasconcelos JC, Riddell A, Murphy C, Kelly J, Bainbridge J, Tudor-Edwards R, Hopkins D, Hykin P, CLARITY Study Group. Lancet; 2017 Jun 03; 389(10085):2193-2203. PubMed ID: 28494920 [Abstract] [Full Text] [Related]
14. Effect of pan-retinal laser photocoagulation on intravitreal vascular endothelial growth factor concentration in proliferative diabetic retinopathy. Nišić F, Pidro A, Lepara O, Fajkić A, Mioković AP, Suljić E, Nišić A, Kovačević I. Rom J Ophthalmol; 2022 Jun 03; 66(3):265-270. PubMed ID: 36349176 [Abstract] [Full Text] [Related]
15. Central retinal thickness following panretinal photocoagulation using a multispot semi-automated pattern-scanning laser to treat ischaemic diabetic retinopathy: Treatment in one session compared with four monthly sessions. Gabrielle PH, Massin P, Kodjikian L, Erginay A, Pallot C, Jonval L, Soudry A, Couturier A, Vardanian-Vartin C, Bron AM, Creuzot-Garcher C. Acta Ophthalmol; 2019 Aug 03; 97(5):e680-e687. PubMed ID: 30561087 [Abstract] [Full Text] [Related]
16. Improvement of visual acuity in eyes with diabetic macular edema after treatment with pars plana vitrectomy. Jahn CE, Töpfner von Schutz K, Richter J, Boller J, Kron M. Ophthalmologica; 2004 Aug 03; 218(6):378-84. PubMed ID: 15564755 [Abstract] [Full Text] [Related]
17. Diabetic macular oedema: pilot randomised trial of pars plana vitrectomy vs macular argon photocoagulation. Patel JI, Hykin PG, Schadt M, Luong V, Bunce C, Fitzke F, Gregor ZJ. Eye (Lond); 2006 Aug 03; 20(8):873-81. PubMed ID: 16052254 [Abstract] [Full Text] [Related]
18. Outcomes of Pars Plana Vitrectomy with Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy Without Retinal Detachment: A Seven-Year Retrospective Study. Patel V, Rohowetz LJ, Pakravan P, Kalavar M, Yannuzzi NA, Sridhar J. Clin Ophthalmol; 2023 Aug 03; 17():471-478. PubMed ID: 36755887 [Abstract] [Full Text] [Related]
19. Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial. Abd Elhamid AH, Mohamed AAEA, Khattab AM. BMC Ophthalmol; 2020 Apr 06; 20(1):130. PubMed ID: 32252674 [Abstract] [Full Text] [Related]
20. Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy. Cho WB, Oh SB, Moon JW, Kim HC. Retina; 2009 Apr 06; 29(4):516-22. PubMed ID: 19262436 [Abstract] [Full Text] [Related] Page: [Next] [New Search]